Skip to main content Accessibility help
×
×
Home

Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015

  • Y. J. PARK (a1), J. M. KIM (a2), B. R. LEE (a3), T. H. KIM (a4) and E. G. LEE (a1)...

Summary

This study evaluated the annual prevalence of anogenital warts (AGW) caused by human papillomavirus (HPV) and analysed the trend in annual per cent changes (APC) by using national claims data from the Health Insurance Review and Assessment of Korea, 2007–2015. We also estimated the socio-economic burden and co-morbidities of AGW. All analyses were performed based on data for primary A63.0, the specific diagnosis code for AGW. The socio-economic cost of AGW was calculated based on the direct medical cost, direct non-medical cost and indirect cost. The overall AGW prevalence and socio-economic burden has increased during the last 9 years. However, the prevalence of AGW differed significantly by sex. The female prevalence increased until 2012, and decreased thereafter (APC + 3·6%). It would fall after the introduction of routine HPV vaccination, principally for females, in Korea. The male prevalence increased continuously over time (APC + 11·6%), especially in those aged 20–49 years. Referring to the increasing AGW prevalence and its disease burden, active HPV infection control surveillance and prevention in males are worth consideration.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: J.-M. Kim, Department of Urology, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, Korea. (Email: urojun@schmc.ac.kr)

References

Hide All
1. Patel, H, et al. Systematic review of the incidence and prevalence of genital warts. BioMed Central Infectious Diseases 2012; 13: 3939.
2. Winer, RL. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American Journal of Epidemiology 2003; 157: 218226.
3. Castle, PE, Maza, M. Prophylactic HPV vaccination: past, present, and future. Epidemiology and Infection 2016; 144: 449468.
4. International Human Papillomavirus Reference Center. Human papillomavirus reference clones. (http://www.hpvcenter.se/html/refclones.html). Accessed 24 October 2017.
5. Insinga, RP, Dasbach, EJ, Myers, ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clinical Infectious Diseases 2003; 36: 13971403.
6. Capra, G, et al. Analysis of persistence of human papillomavirus infection in men evaluated by sampling multiple genital sites. European Review for Medical and Pharmacological Sciences 2015; 19: 41534163.
7. Pellati, D, et al. Genital tract infections and infertility. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008; 140: 311.
8. Patel, RV, Yanofsky, VR, Goldenberg, G. Genital warts: a comprehensive review. Journal of Clinical and Aesthetic Dermatology 2012; 5: 2536.
9. Markowitz, LE, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Recommendations and Reports 2014; 63: 130.
10. Satterwhite, CL, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sexually Transmitted Diseases 2013; 40: 187193.
11. Shin, H-R, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. Journal of Infectious Diseases 2004; 190: 468476.
12. Park, SJ, et al. Prevalence and determinants of high-risk human papillomavirus infection in male genital warts. Korean Journal of Urology 2014; 55: 207212.
13. Centers for Disease Control Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males – advisory committee on immunization practices (ACIP), 2011. MMWR Morbidity and Mortality Weekly Report 2011; 60: 1705.
14. Kim, MK, No, JH, Song, YS. Human papillomavirus vaccine. Journal of the Korean Medical Association 2009; 52: 11801186.
15. Anon. Human papillomavirus vaccines. WHO position paper. Weekly Epidemiological Record 2009; 84: 118131.
16. Anon. Human papillomavirus vaccines: WHO position paper, October 2014-recommendations. Vaccine 2015; 33: 43834384.
17. Capra, G, et al. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: a referral hospital-based study in Sicily. Human Vaccines & Immunotherapeutics 2017; 13: 18391843.
18. Li, N, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. International Journal of Cancer 2011; 128: 927935.
19. Ali, H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. British Medical Journal 2013; 346: f2032.
20. Hartwig, S, et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012; 12: 30.
21. Read, TR, et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sexually Transmitted Infections 2011; 87: 544547.
22. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th edn. Geneva, CH: World Health Organization, 1989.
23. Korean Statistical Information Service. Korea national statistical office. (http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A) 2017.
24. Jung, YH, Ko, S. The socioeconomic cost of diseases in Korea. Journal of Preventive Medicine and Public Health Yebang Uihakhoe Chi 2006; 39: 499504.
25. Park, CS, et al. Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database. Journal of Preventive Medicine and Public Health Yebang Uihakhoe Chi 2006; 39: 397403.
26. National Health Insurance Corporation. Survey of Medical Charges Paid by Patients with Health Insurance in 2010. Seoul: National Health Insurance Corporation, 2010.
27. Korea Institute for Health and Social Affairs (KIHASA). The basic analysis report of Korean health panel survey in 2008. (https://www.kihasa.re.kr/web/activity/research/view.do?menuId=39&tid=72&bid=93&division=003&ano=545) 2017.
28. Drummond, MF, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford, UK: Oxford University Press, 2005.
29. No, IC, Suh, MH, Kim, YL. Socioeconomic Costs of Alcohol and Policy Issues. Seoul: Korea Institute of Health and Social Affairs, 1997.
30. Future I/II Study Group, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ: British Medical Journal 2010; 341: c3493.
31. Garland, SM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine 2007; 356: 19281943.
32. Drolet, M, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infectious Diseases 2015; 15: 565580.
33. Giuliano, AR, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New England Journal of Medicine 2011; 364: 401411.
34. Markowitz, LE, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. Journal of Infectious Diseases 2013; 208: 385393.
35. Kann, L, et al. Youth risk behavior surveillance – United States, 2015. MMWR Surveillance Summaries 2016; 65: 1174.
36. Seoul Mental Health Statistics. A study based on the 10th (2014) adolescent health behavior online survey. (https://www.seoulmentalhealth.kr/dataroom/data.jsp?cmd=view&test_num=63) 2017.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
WORD
Supplementary materials

Park et al supplementary material
Table S1

 Word (28 KB)
28 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed